Ambrisentan 5 mg

DRUG3 trials

Sponsors

Robert J Noveck, M.D., GlaxoSmithKline

Conditions

Acute Mountain Sickness and FatigueHypertension

Phase 1

A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude

CompletedNCT01794078

Robert J Noveck, M.D.Acute Mountain Sickness and Fatigue

Start: 2013-09-30End: 2014-12-31Updated: 2015-11-13

Phase 3

Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension.

TerminatedNCT01884675

GlaxoSmithKlineHypertension

Start: 2013-09-30End: 2015-03-31Updated: 2017-03-06

A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

TerminatedNCT01894022

GlaxoSmithKlineHypertension

Start: 2014-01-23End: 2015-11-18Updated: 2017-09-11